Since tumors are classified as immunologically “cold” (CD8+ T cell-decreased) or “hot” (CD8+ T cell-enriched), and their immune status is closely associated with tumor prognosis30, we further investigated the prognostic role of NEK2 in increased or decreased CD8+ T cell pancreatic cancer. This evidence concerns the gene NEK2 and neoplasm.